Charles R Rogers1, Justin X Moore2,3, Fares Qeadan1, Lily Y Gu1, Matthew S Huntington1, Andreana N Holowatyj4,5,6. 1. Department of Family and Preventive Medicine, University of Utah School of Medicine 375 Chipeta Way, Suite A, Salt Lake City, Utah, USA. 2. Department of Population Health Sciences, Augusta University 1120 15th St. AE-1037, Augusta, Georgia, USA. 3. Institute of Public and Preventive Health, Augusta University Augusta, Georgia, USA. 4. Vanderbilt University Medical Center 2525 West End Ave., Nashville, Tennessee, USA. 5. Vanderbilt-Ingram Cancer Center Nashville, Tennessee, USA. 6. Department of Population Health Sciences, University of Utah School of Medicine 295 Chipeta Way, Salt Lake City, Utah, USA.
Abstract
Background: Despite overall incidence reduction in colorectal cancer (CRC) the past 32 years, unexplained incidence and mortality rates have increased significantly in younger adults ages 20-49. To improve understanding of sex-specific differences among this population, we aimed to determine the variance in early-onset CRC (EOCRC) survival among US men diagnosed with CRC before age 50, while considering individual- and county-level CRC outcome determinants. Methods: Hotspots (i.e., counties with high EOCRC mortality rates) were derived from Centers for Disease Control and Prevention data from 1999-2017, and linked to SEER data for men aged 15-49 years with CRC. Cox proportional hazards models were used to compare CRC-specific survival probability and hazard in hotspots versus non-significant counties. A generalized R2 was used to estimate the total variance in EOCRC survival explained by clinicodemographic and county-level determinants. Results: We identified 232 hotspot counties for EOCRC-214 (92%) of which were in the South. In hotspots, 1,009 men were diagnosed with EOCRC and 31,438 in non-significant counties. After adjusting for age, race, tumor stage and grade, surgery, chemotherapy, radiation therapy, and marital status, men residing in hotspot counties had higher hazard of CRC-specific death (HR 1.24, 95% CI, 1.12-1.36). Individual/county-level factors explained nearly 35% of the variation in survival, and adult smoking served as the strongest county-level determinant of EOCRC survival. Conclusion: Distinct geographic patterns of EOCRC were predominantly located in the southern US. Survival after EOCRC diagnosis was significantly worse among men residing in hotspot counties. AJCR
Background: Despite overall incidence reduction in colorectal cancer (CRC) the past 32 years, unexplained incidence and mortality rates have increased significantly in younger adults ages 20-49. To improve understanding of sex-specific differences among this population, we aimed to determine the variance in early-onset CRC (EOCRC) survival among US men diagnosed with CRC before age 50, while considering individual- and county-level CRC outcome determinants. Methods: Hotspots (i.e., counties with high EOCRC mortality rates) were derived from Centers for Disease Control and Prevention data from 1999-2017, and linked to SEER data for men aged 15-49 years with CRC. Cox proportional hazards models were used to compare CRC-specific survival probability and hazard in hotspots versus non-significant counties. A generalized R2 was used to estimate the total variance in EOCRC survival explained by clinicodemographic and county-level determinants. Results: We identified 232 hotspot counties for EOCRC-214 (92%) of which were in the South. In hotspots, 1,009 men were diagnosed with EOCRC and 31,438 in non-significant counties. After adjusting for age, race, tumor stage and grade, surgery, chemotherapy, radiation therapy, and marital status, men residing in hotspot counties had higher hazard of CRC-specific death (HR 1.24, 95% CI, 1.12-1.36). Individual/county-level factors explained nearly 35% of the variation in survival, and adult smoking served as the strongest county-level determinant of EOCRC survival. Conclusion: Distinct geographic patterns of EOCRC were predominantly located in the southern US. Survival after EOCRC diagnosis was significantly worse among men residing in hotspot counties. AJCR
Authors: Min Lian; Mario Schootman; Chyke A Doubeni; Yikyung Park; Jacqueline M Major; Rosalie A Torres Stone; Adeyinka O Laiyemo; Albert R Hollenbeck; Barry I Graubard; Arthur Schatzkin Journal: Am J Epidemiol Date: 2011-08-11 Impact factor: 4.897
Authors: Rebecca L Siegel; Liora Sahar; Kenneth M Portier; Elizabeth M Ward; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2015-07-24 Impact factor: 508.702
Authors: Andreana N Holowatyj; Julie J Ruterbusch; Laura S Rozek; Michele L Cote; Elena M Stoffel Journal: J Clin Oncol Date: 2016-05-02 Impact factor: 44.544
Authors: Charles R Rogers; Roger Figueroa; Ellen Brooks; Ethan M Petersen; Carson D Kennedy; Darrell M Gray Ii; Michael Sapienza; Man Hung Journal: Am J Cancer Res Date: 2021-12-15 Impact factor: 6.166
Authors: Charles R Rogers; Kevin M Korous; Ellen Brooks; Mary A De Vera; Fa Tuuhetaufa; Todd Lucas; Karen Curtin; Curt Pesman; Wenora Johnson; Phuong Gallagher; Justin X Moore Journal: Am Soc Clin Oncol Educ Book Date: 2022-04
Authors: Charles R Rogers; Ellen Brooks; Karen Curtin; Mary A De Vera; Fares Qeadan; Tiana N Rogers; Ethan Petersen; Phuong Gallagher; Curt Pesmen; Wenora Johnson; Candace Henley; Walter Hickman; Elaine Newcomb; Kevin M Korous; Margaret A Handley Journal: BMJ Open Date: 2021-12-03 Impact factor: 2.692
Authors: Andreana N Holowatyj; Richard Viskochil; Dominik Ose; Benjamin Tingey; Benjamin Haaland; Dalton Wilson; Mikaela Larson; Sara Feltz; Mark A Lewis; Howard Colman; Cornelia M Ulrich Journal: J Adolesc Young Adult Oncol Date: 2020-07-29 Impact factor: 2.223
Authors: Lihchyun Joseph Su; Sean G Young; Josephine Collins; Eryn Matich; Ping-Ching Hsu; Tung-Chin Chiang Journal: Int J Environ Res Public Health Date: 2022-03-10 Impact factor: 3.390